Literature DB >> 11045909

Soluble guanylate cyclase and cGMP-dependent protein kinase I expression in the human corpus cavernosum.

T Klotz1, W Bloch, J Zimmermann, P Ruth, U Engelmann, K Addicks.   

Abstract

Nitric oxide (NO) as a mediator in smooth muscle cells causes rapid and robust increases in cGMP levels. The cGMP-dependent protein kinase I has emerged as an important signal transduction mediator for smooth muscle relaxation. The purpose of this study was to examine the existence and distribution of two key enzymes of the NO/cGMP pathway, the cGMP-dependent kinase I (cGK I) and the soluble guanylate cyclase (sGC) in human cavernosal tissue. The expression of the enzymes were examined in corpus cavernosum specimens of 23 patients. Eleven potent patients suffered from penile deviations and were treated via Nesbit's surgical method. Nine long-term impotent patients underwent implantation of flexible hydraulic prothesis. Three potent patients underwent trans-sexual operations. Expression of the sGC and cGK I were examined immunohistochemically using specific antibodies. In all specimens of cavernosal tissue a distinct immunoreactivity was observed in different parts and structures. We found a high expression of sGC and cGK I in smooth muscle cells of vessels and in the fibromuscular stroma. The endothelium of the cavernosal sinus, of the cavernosal arteries, and the cavernosal nerve fibers showed an immunoreactivity against sGC. The distribution analysis of cGK I revealed a predominately vesicular localization in smooth muscle cells. The examination of the endothelium showed no clear immunoreactivity against cGK I. There was no distinct difference in immunoreactivity and cellular distribution between potent and impotent patients.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11045909     DOI: 10.1038/sj.ijir.3900524

Source DB:  PubMed          Journal:  Int J Impot Res        ISSN: 0955-9930            Impact factor:   2.896


  7 in total

1.  Protein kinase enzymes in the human vagina-relation to key mediators of the cyclic AMP and cyclic GMP pathways.

Authors:  S Ückert; J Sonnenberg; J E Sonnenberg; W Kauffels; K Albrecht; M A Kuczyk; P Hedlund
Journal:  Int J Impot Res       Date:  2017-04-13       Impact factor: 2.896

Review 2.  Stimulators and activators of soluble guanylate cyclase for urogenital disorders.

Authors:  Fabiola Z Mónica; Edson Antunes
Journal:  Nat Rev Urol       Date:  2017-11-14       Impact factor: 14.432

3.  Involvement of beta 3-adrenergic receptor activation via cyclic GMP- but not NO-dependent mechanisms in human corpus cavernosum function.

Authors:  Giuseppe Cirino; Raffaella Sorrentino; Roberta d'Emmanuele di Villa Bianca; Ada Popolo; Alessandro Palmieri; Ciro Imbimbo; Ferdinando Fusco; Nicola Longo; Gianfranco Tajana; Louis J Ignarro; Vincenzo Mirone
Journal:  Proc Natl Acad Sci U S A       Date:  2003-04-21       Impact factor: 11.205

4.  Erectile dysfunction in mice lacking the large-conductance calcium-activated potassium (BK) channel.

Authors:  Matthias E Werner; Peter Zvara; Andrea L Meredith; Richard W Aldrich; Mark T Nelson
Journal:  J Physiol       Date:  2005-07-14       Impact factor: 5.182

5.  [Sexual dysfunction at urinary incontinence].

Authors:  J B Korda; M Braun; U H Engelmann
Journal:  Urologe A       Date:  2007-09       Impact factor: 0.639

6.  Additive effects of Artemisia capillaris extract and scopoletin on the relaxation of penile corpus cavernosum smooth muscle.

Authors:  B R Choi; S K Kumar; C Zhao; L T Zhang; C Y Kim; S W Lee; J-H Jeon; K K Soní; I So; S H Kim; N C Park; H K Kim; J K Park
Journal:  Int J Impot Res       Date:  2015-10-08       Impact factor: 2.896

7.  Exploring scientifically proven herbal aphrodisiacs.

Authors:  Sabna Kotta; Shahid H Ansari; Javed Ali
Journal:  Pharmacogn Rev       Date:  2013-01
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.